Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2026-09-08 20:02:03 ET · period of report 2026-09-04 · accession 0001193125-26-385541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 20:02 | 2026-09-04 | SRPT | Rothfuss Cristin | EVP, GC | F - Tax | $22.22 | -22.0K | 115.5K | -16% | -$489.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-04 | F | D | 22,025 | $22.22 | 115,519 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025. |